The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content


AEterna Zentaris Inc closed at $4.08.

Over the last five days, shares have lost 5.77% and are down 15.70% for the last year to date. This security has underperformed the S&P TSX by 28.54% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$4.11
Updated at previous session's close. Delayed by at least 15 minutes.


Net Profit (TTM)

AEterna Zentaris Inc has a net profit margin of -3,777.43%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense87710
Selling / general / administrative3446
Research & development5444
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-8-7-7-10
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Income before tax-6-7-4-10
Income after tax-6-7-4-10
Income tax, total--------
Net income-6-7-4-10
Total adjustments to net income--------
Net income before extra. items-6-7-4-10
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-6-7-4-10
Inc. avail. to common incl. extra. items-6-7-4-10
Diluted net income-6-7-4-10
Dilution adjustment--------
Diluted weighted average shares1010107
Diluted EPS excluding extraordinary itemsvalue per share-0.61-0.71-0.37-1.45
Dividends per sharevalue per share0.
Diluted normalized EPSvalue per share-0.61-0.71-0.37-1.45